These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 11358396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Iron overload syndrome in the black rhinoceros (Diceros bicornis): microscopical lesions and comparison with other rhinoceros species.
    Olias P, Mundhenk L, Bothe M, Ochs A, Gruber AD, Klopfleisch R.
    J Comp Pathol; 2012 Nov; 147(4):542-9. PubMed ID: 22935088
    [Abstract] [Full Text] [Related]

  • 3. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload.
    Lee PL, Halloran C, West C, Beutler E.
    Blood Cells Mol Dis; 2001 Nov; 27(1):285-9. PubMed ID: 11358389
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
    Townsend A, Drakesmith H.
    Lancet; 2002 Mar 02; 359(9308):786-90. PubMed ID: 11888608
    [Abstract] [Full Text] [Related]

  • 6. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P, Esculié-Coste C, Bismuth M, Giansily-Blaizot M, Larrey D, Schved JF.
    Blood Cells Mol Dis; 2001 Mar 02; 27(1):290-3. PubMed ID: 11358390
    [Abstract] [Full Text] [Related]

  • 7. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F, Zecchina G, Sbaiz L, Fischer R, Piga A, Camaschella C.
    Haematologica; 1999 Sep 02; 84(9):799-803. PubMed ID: 10477452
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V, Ryan E, O'Keane C, Crowe J.
    Blood Cells Mol Dis; 2000 Feb 02; 26(1):2-8. PubMed ID: 10772870
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relation between HFE mutations and mild iron-overload expression.
    Mura C, Le Gac G, Raguénes O, Mercier AY, Le Guen A, Férec C.
    Mol Genet Metab; 2000 Apr 02; 69(4):295-301. PubMed ID: 10870847
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
    Barton JC, Lee PL, West C, Bottomley SS.
    Am J Hematol; 2006 Oct 02; 81(10):760-7. PubMed ID: 16838333
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.